(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HERPHEGEN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

HERPHEGEN

ST13

US500000079262917

Classe

1, 5, 35, 39, 41, 42, 44

Pedido

79262917

Registro

6077138

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

33

Atualização mais recente

17/06/2025

Tipo de marca

Verbal

Classes Nice

1, 5, 35, 39, 41, 42, 44

Data de depósito

22/02/2019

Data de registro

16/06/2020

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/06/2020

Última transação

17/06/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

SEGAL, MOLLY

Unidade examinadora

L50

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

The Secretary of State for Health and Social Care

Representantes

Rebecca Liebowitz VENABLE LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 35Classe 39Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals for use in science; biological preparations for use in science; chemical products and substances for in vitro use for use in industry and science; micro-organismscultures and preparations of micro-organisms for laboratory use and for scientificresearch and testing purposesother than for medical use; reagent kits comprising generic DNA circleDNA primerspolymerase and buffers for use in biotechnology research purposes; Enzymes for laboratory use and for scientificresearch and testing purposesfor use in the continuous homogenous isothermal amplifications of specific DNA templates; agar and glycerol for the storage of micro-organisms and bacteria

Classe 5

Pharmaceutical preparations for diagnosing and treating herpes virus infections; diagnostic preparations and substances for medical purposes; diagnostic preparations and substances for medical purposes and all for in vivo use; cultures for medical use; micro-organismsbacteria and cultures and preparations of micro-organisms for medical and veterinary use; media for bacteriological cultures; nutritive substances for micro-organisms for medical purposes; chemical preparations for use in DNA analysis for medical purposes

Classe 35

Database management; database marketing; computerized database management; compilation of information into computer databases

Classe 39

Transportpackaging and storage of goods; transport of DNA samples; packaging and storage of DNA samples; storage of micro-organismsbacteria and cultures of micro-organisms and bacteria

Classe 41

Educationproviding both online and in-person classesseminarsworkshops in the fields of healthcareantiviral resistanceantiviral testing and database interpretation and management; providing of training in the fields of healthcareantiviral resistanceantiviral testing and database interpretation and management; teaching in the fields of healthcareantiviral resistanceantiviral testing and database interpretation and management; arranging and conducting of conferencesseminars and training workshops for educational purposes; Education in the fields of healthcareantiviral resistanceantiviral testing and database interpretation and management rendered through correspondence courses; vocational guidance; organisation of exhibitions for educational purposes; Providing on-line non-downloadable publications in the nature of educational course materialsnewslettersreportsjournalsstudies and evaluations relating to healthcareantiviral resistanceantiviral testing and database interpretation and management

Classe 42

Research servicesmedical researchpharmaceutical research and scientific research; research and development servicesmedicalpharmaceutical and scientific research and development services; consultancy services in the field of research and developmentmedical research and medical product developmentpharmaceutical research and developmentscientific research and development; dissemination of information in the field of scientific research and developmentall relating to biologicalmicrobiologicalmicrobialgeneticchromosomalenvironmentalbiosafetyimmunologypharmacologyhealth matters; scientific consultancy services relating to biologicalmicrobiologicalmicrobialgeneticchromosomalenvironmentalbiosafetyimmunologypharmacologyhealth; laboratory analysislaboratory research and laboratory testing services; scientific consultancy services relating to biologicalmicrobiologicalmicrobialgeneticchromosomalenvironmentalbiosafetybioterrorismimmunologypharmacology or health matters; providing scientific research information relating to biologicalmicrobiologicalmicrobialgeneticchromosomalenvironmentalbiosafetybioterrorismimmunologypharmacology or health matters; clinical research servicescollection of clinical data for scientificmedical and pharmaceutical research purposes; DNA screening for scientific research purposes

Classe 44

Medical services; veterinary services; health care; hospital services and medical clinics; medical assistance; nursing services; medical and healthcare services relating to DNAgenetics and genetic testinggenetics and genetic testing

Publicações

Histórico de despachos e eventos da marca no USPTO.

33 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

16/06/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

28/11/2020

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

06/10/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

05/10/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

16/09/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

16/06/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/03/2020

PUBO

PUBLISHED FOR OPPOSITION

31/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/02/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

26/02/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

26/02/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

26/02/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

26/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/02/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/02/2020

ALIE

ASSIGNED TO LIE

25/02/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/02/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

20/02/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/02/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

20/02/2020

DOCK

ASSIGNED TO EXAMINER

12/11/2019

RFNT

REFUSAL PROCESSED BY IB

06/09/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

21/08/2019

RFRR

REFUSAL PROCESSED BY MPU

21/08/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

25/07/2019

CNRT

NON-FINAL ACTION WRITTEN

24/07/2019

MAFR

APPLICATION FILING RECEIPT MAILED

20/07/2019

DOCK

ASSIGNED TO EXAMINER

16/07/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/07/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/07/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HERPHEGEN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.